Rathbones Group’s Centessa Pharmaceuticals CNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $217K | Hold |
16,500
| – | – | ﹤0.01% | 544 |
|
|
2025
Q1 | $237K | Sell |
16,500
-150
| -0.9% | -$2.16K | ﹤0.01% | 501 |
|
|
2024
Q4 | $279K | Sell |
16,650
-13,750
| -45% | -$230K | ﹤0.01% | 479 |
|
|
2024
Q3 | $486K | Sell |
30,400
-900
| -3% | -$14.4K | ﹤0.01% | 420 |
|
|
2024
Q2 | $283K | Hold |
31,300
| – | – | ﹤0.01% | 498 |
|
|
2024
Q1 | $354K | Hold |
31,300
| – | – | ﹤0.01% | 461 |
|
|
2023
Q4 | $249K | Hold |
31,300
| – | – | ﹤0.01% | 501 |
|
|
2023
Q3 | $203K | Buy |
+31,300
| New | +$203K | ﹤0.01% | 538 |
|